YR1171
科研级 Raxibacumab ( 雷昔库单抗 ), Anti-Protective Antigen Recombinant Antibody, Research Grade Raxibacumab
| Alias | 科研级 Raxibacumab ( 雷昔库单抗 ), Anti-Protective Antigen Recombinant Antibody, Research Grade Raxibacumab |
| Catalog Number | YR1171 |
| Molecular Name | Raxibacumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Lambda |
| Formulation | PBS, pH7.5 |
| Background | Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys. In December 2012 raxibacumab was approved in the United States for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate. |
| CAS Number | 565451-13-0 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Molecular Weight | 142.84 kDa |
| Target | Anthrax protective antigen[Bacillus anthracis] |
Service Account
0
